Insider Trading History of Wijngaard Peter

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wijngaard Peter since 1. This trader's CIK number is 1778501. At the time of last reporting, Wijngaard Peter was the Officer of Hepion Pharmaceuticals, Inc.. (stock ticker symbol HEPA). Also see all insider trading activities at Hepion Pharmaceuticals, Inc..

Note that in the past Wijngaard Peter also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Medicines Co /de (MDCO) by Wijngaard Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MDCO 0 $0 0 $0 329,439 $10,703,143
2019 MDCO 0 $0 0 $0 329,439 $10,703,143

Yearly summary of insider trading at Hepion Pharmaceuticals, Inc. (HEPA) by Wijngaard Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 HEPA 8,000 $32,084 0 $0 0 $0
2021 HEPA 10,000 $22,000 0 $0 0 $0
2020 HEPA 20,000 $38,200 0 $0 0 $0


Insider trading activities at 2 companies by Wijngaard Peter:

1. Medicines Co /de (MDCO)

2. Hepion Pharmaceuticals, Inc. (HEPA)

Table 1. Insider trading of Medicines Co /de (MDCO) by Wijngaard Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-27 MDCO Option Ex 329,439 32.49 10,703,143
2019-12-27 MDCO Option Ex 329,439 32.49 10,703,143

Table 2. Insider trading of Hepion Pharmaceuticals, Inc. (HEPA) by Wijngaard Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-27 HEPA Buy 2,500 3.05 7,625
2023-11-24 HEPA Buy 2,500 3.09 7,725
2023-09-19 HEPA Buy 1,000 5.64 5,640
2023-09-15 HEPA Buy 2,000 5.55 11,094
2021-02-16 HEPA Buy 10,000 2.20 22,000
2020-12-18 HEPA Buy 20,000 1.91 38,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wijngaard Peter (Officer of Hepion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.